Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3938 per EA under NDC 00093874101. Its NADAC has been published 574 times since Nov 28, 2013.
FDA first approved this application on May 16, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093874101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074377FDA Approved
5/16/1995
TE Code
AB
On Market Since
6/5/1995
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 574 times since Nov 28, 2013, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3938 per EA |
|---|---|
| All-time high | $1.5484 (Mar 13, 2019) |
| All-time low | $0.3938 (Aug 19, 2026) |
| 52-week high | $0.4943 |
| 52-week low | $0.3938 |
| Median price | $1.0959 |
| Average price | $1.0002 |
| Largest weekly change | +88.6% (Nov 19, 2014) |
| Weeks tracked | 574 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.3938 per EA (NDC 00093874101), effective Aug 19, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has declined 10.5%. It has been tracked across 574 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.3938 (Aug 19, 2026) to a high of $1.5484 (Mar 13, 2019), with a median of $1.0959 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEXILETINE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 00093874101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.